BioCentury
ARTICLE | Clinical News

Xoma regulatory update

January 9, 1995 8:00 AM UTC

XOMA received U.S. Patent No. 5,376,546 containing the first composition of matter claims for analogs of the Berkeley, Calif., company's recombinant DNA-derived gelonin. rGelonin is a ribosome-inactiv...